HB 351 (see companion bill SB 1494) – Florida

Status: Enacted
Year Introduced: 2017
Link: https://www.flsenate.gov/Session/Bill/2018/00351

PRESCRIPTION DRUG PRICING TRANSPARENCY: Requires pharmacists to inform customers of certain generically equivalent drug products & whether cost-sharing obligations to such customers exceed retail price of prescription; provides that a contract between a health insurer and a pharmacy benefit manager must prohibit the pharmacy benefit manager from requiring an insured to make a payment for a prescription drug at the point of sale in an amount that exceeds the lesser of: (a) The applicable cost-sharing amount; or (b) The retail price of the drug in the absence of prescription drug coverage.

Requires PBM registration with OIR; provides registration requirements; requires registrant to report certain changes by specified date; requires office to issue registration certificate upon receipt of completed registration form; provides for expiration; requires rulemaking; requires certain terms in health insurer or health maintenance organization contracts with pharmacy benefit managers.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment